Literature DB >> 8916152

Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions.

T Yamada1, T Kakihara, T Kamishima, T Fukuda, T Kawai.   

Abstract

The polymorphic protein, serum amyloid A (SAA), consists of acute phase isotypes and a constitutive isotype. Both are associated mostly with high density lipoproteins (HDL) in the circulation. In the present study, both SAA isotypes were detected by immunohistochemistry and immunoblotting using monoclonal antibodies in atherosclerotic lesions. As the distribution of SAA was identical with that of apolipoprotein B and SAA is known to be associated also with low density lipoproteins (LDL), SAA may also be delivered to the artery wall by LDL.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916152     DOI: 10.1111/j.1440-1827.1996.tb03552.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  16 in total

Review 1.  Role of serum amyloid A in atherosclerosis.

Authors:  Preetha Shridas; Lisa R Tannock
Journal:  Curr Opin Lipidol       Date:  2019-08       Impact factor: 4.776

2.  [Lipoproteins and diabetic nephropathy].

Authors:  T Bertsch; J Aufenanger
Journal:  Med Klin (Munich)       Date:  1998-01-15

3.  Trafficking of endogenous smooth muscle cell cholesterol: a role for serum amyloid A and interleukin-1β.

Authors:  Lawrence G Pessolano; Christopher P Sullivan; Stephanie E Seidl; Celeste B Rich; Laura Liscum; Phillip J Stone; Jean D Sipe; Barbara M Schreiber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-20       Impact factor: 8.311

4.  Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis.

Authors:  B M Schreiber; M Veverbrants; R E Fine; J K Blusztajn; M Salmona; A Patel; J D Sipe
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

5.  Serum amyloid A is not incorporated into HDL during HDL biogenesis.

Authors:  Ailing Ji; Xuebing Wang; Victoria P Noffsinger; Drew Jennings; Maria C de Beer; Frederick C de Beer; Lisa R Tannock; Nancy R Webb
Journal:  J Lipid Res       Date:  2020-01-08       Impact factor: 5.922

6.  Serum Amyloid A Is an Exchangeable Apolipoprotein.

Authors:  Patricia G Wilson; Joel C Thompson; Preetha Shridas; Patrick J McNamara; Maria C de Beer; Frederick C de Beer; Nancy R Webb; Lisa R Tannock
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

Review 7.  Amyloid in the cardiovascular system: a review.

Authors:  I Kholová; H W M Niessen
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

8.  Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue.

Authors:  Andrew P Lane; Quynh-Ai Truong-Tran; Allan Myers; Carol Bickel; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2006 Jan-Feb

9.  Secretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism.

Authors:  Christopher P Sullivan; Stephanie E Seidl; Celeste B Rich; Michel Raymondjean; Barbara M Schreiber
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

10.  Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.

Authors:  Patricia G Wilson; Joel C Thompson; Nancy R Webb; Frederick C de Beer; Victoria L King; Lisa R Tannock
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.